Pinsent Masons advises Statkraft on landmark offshore wind partnership with Copenhagen Infrastructure Partners

17 Jan 2023 | 03:26 pm | 1 min. read

Multinational law firm Pinsent Masons has advised Statkraft on the sale of a 50% stake in their Irish offshore wind portfolio to Copenhagen Infrastructure Partners’ fund, Copenhagen Infrastructure IV K/S, as part of its plans to develop up to 2.2 gigawatts of offshore wind in Ireland.

The partnership includes the development of offshore wind development projects North Irish Sea Array (NISA), located in the Irish Sea off the coast of counties Dublin, Louth and Meath, and Bore Array in the Celtic Sea. The development and construction of the projects is expected to exceed a €4 billion investment by Statkraft and Copenhagen Infrastructure Partners by 2030.

The Pinsent Masons team acting on the transaction was led by Senior Associate Sarah Hope and Partners Richard Murphy and Oisin McLoughlin in the firm’s Ireland Energy practice and included a range of specialist advice and experience on offshore wind from a number of offices across the UK and Germany.

Commenting on the deal, Sarah Hope said:

"This partnership is a significant development for Ireland’s renewable energy market. Bringing two leading renewable energy developers together provides huge opportunity in terms of the scale of offshore wind energy production that can be provided to the Irish population. The portfolio under the partnership includes the North Irish Sea Array project which is one of the seven “Relevant Projects”, which are the first phase of projects intended to assist Ireland in meeting its target of 7 GW of offshore wind energy by 2030.

Our energy practice has now advised on transactions involving three of the seven “Relevant Projects” for offshore wind, having previously advised EDF on the acquisition of a 50% interest in Codling Wind Park I and II.”

Statkraft is Europe’s largest generator of renewable energy. The company entered the Irish market in 2018 and since then has almost tripled its workforce and tripled its development portfolio. A leading player in the Irish renewable energy market, it develops, owns, and operates renewable energy projects across the technologies of onshore wind, offshore wind, solar, battery storage and grid services.  

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London

Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises La Bottega on Australian acquisition

Multinational law firm Pinsent Masons has advised Italian producer of hotel essentials La Bottega on its acquisition of a majority stake in Australian company Vanity Group.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises SUSI Partners on investment in Alba Renewables

Law firm Pinsent Masons MPillay has advised Swiss-based infrastructure investment manager SUSI Partners on its investment in Alba Renewables to build a renewable energy infrastructure business focused on The Philippines.

Pinsent Masons advises Bestinver Infra, FCR on acquisition of remaining shares in Irish toll road concession & operation companies

Pinsent Masons has advised Bestinver Infra, FCR on the acquisition of the remaining shares in N6 (Concession) Holdings Limited and N6 (Operations) Ltd, with Japanese co-investor Daiwa Energy & Infrastructure Co. Ltd.

Pinsent Masons advises Sandoz on acquisition of remaining shares in Rowex Joint Venture

Multinational law firm Pinsent Masons has advised Sandoz on the acquisition of the remaining shares in Rowex Limited, a joint venture in Ireland between Sandoz and Rowa Pharmaceuticals.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.